NCT01429818View on ClinicalTrials.gov

Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Endothelial DysfunctionDiabetes Mellitus
Interventions
DRUG

Glimepiride/metformin

4/1000 mg tablets once a day foe eight weeks

DRUG

Metformin

1000 mg tablets once daily for eight weeks

Trial Locations (1)

04510

Unidad PET Ciclotrón. Facultad de Medicina. Universidad Nacional Autónoma de México, Mexico City

All Listed Sponsors
lead

Laboratorios Silanes S.A. de C.V.

INDUSTRY

NCT01429818 - Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients | Biotech Hunter | Biotech Hunter